Next generation
heart valve technology

creating the Future

Our Hyaluronan-Enhanced, Polymeric Transcatheter Aortic Valves are inspired by nature and perfected by engineers.

3

YoungHeartValve has 3 patents approved or pending in the US and worldwide

OPTION TO THE LICENSE

Lorem ipsum doler sit.

##

Research Publications

Lorem ipsum doler sit.

$450K+

GRANTS AWARDED

YoungHeartValve successfully raised double the normal amount for an NIH SBIR Phase 1

YHV

THE Future is Now

About YoungHEARTVALVE

Founded by leaders in the structural heart space, we are changing the future of heart valve intervention. Our valves eliminate the need for animal tissue.

YoungHeartValve’s RejuvenateTM TAVR device incorporates hyaluronan into its leaflets, creating a proven thrombosis- and calcification-resistant biomolecular interpenetrated network.

Our valves are engineered for lifetime patient care without the need for multiple interventions and everyday medication management.

Our LEADERSHIP

Meet THE Team
Prasad Dasi, Ph.D.
Co-Founder, CTO
SUSAN JAMES
Co-Founder
Todd Tomba
CEO, YoungHeartValve Inc.

YHV

Our Advantages

What Sets Us Apart

There are many options for heart valves available today, but none quite like ours.

YoungHeartValve's technology is truly the wave of the future for people living with valve disease. Longer lasting valves with no reliance on anticoagulants is finally achievable.

Vinod Thourani, MD Cardiovascular Surgeon, Piedmont Heart Institute

When it come to heart valves, tissue is the issue, and YoungHeartValve has solved that problem.

Prasad Dasi, Ph.D. CTO YoungHeartValve, Founder & CTO of DasiSim

Biomolecule Anti-Calcific Anti-Thrombotic

The hyaluronan molecular network mimics the body's own valve, which provides durability approaching that of mechanical valves.

RejuvenateTM

YHV's biopolymer valves are built for endurance. Testing done so far shows success rates that will last a lifetime instead of needing repeat interventions.

Balloon Expandable

Balloon expansion is easier on the surrounding tissue and leaflets, which allows our biopolymer valves to fit more naturally, decreases risk, and increases patient safety and outcomes.

Superior Para-Valvular Leakage Prevention via proprietary dynamic sealing technology

Our unique, patent-pending technology allows for less leakage caused by space left between natural heart tissue and the valve replacement.

Proven Hemocapatability and Anti-Calcification

Our biopolymer valves have proven hemocapatibility leading to fewer problems with haemolysis, thrombosis and calcification.

Scalable Manufacturing

Because our biopolymer valves do not require animal tissue or time-intensive labor, the manufacturing is incredbly scalable.